<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

New Drugs Approved in 2020

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2021 English Publisher:Elsevier BVJournal:The American Journal of Medicine, volume 134, pages 1,096-1,100 (issn: 0002-9343,

Authors: Alex M Ebied; Hesham Elmariah; Rhonda M Cooper-DeHoff;

doi: 10.1016/j.amjmed.2021.03.034

pmid: 33939997

New Drugs Approved in 2020

- Summary
- Subjects
- Metrics

Abstract

In 2020, the US Food and Drug Administration approved 53 novel drugs. Thirty-six of the 53 (68%) drugs were reviewed and approved through an expedited review pathway, and 31 of the 53 (58%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2020.

Related Organizations

Florida Southern College
United States
Ross University
United States
High Point University
United States
Ross University School of Medicine
Barbados

Keywords

Rare Diseases, Drug Therapy, Pharmaceutical Preparations, Humans, Drug Approval, United States

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average